Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults
Covid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two doses of either Covishield or Covaxin.
Jan 18, 2023, 16:55 PM IST
Fraudsters dupe Serum Institute of over Rs 1 crore by asking for money in CEO Adar Poonawalla's name
One of the directors of the SII received WhatsApp messages from a person who posed as Adar Poonawalla. The sender asked him to transfer money to certain bank accounts immediately. Believing that it was the CEO who had messaged, the company officials transferred Rs 1.01 crore.
Sep 11, 2022, 09:10 AM IST
GOOD NEWS for India's daughters! Country's FIRST cervical cancer vaccine to be launched today
"It is very effective and prevents cervical cancer because, in 85 per cent to 90 per cent of cases, cervical cancer is because of this particular virus and this vaccine is against those viruses," Dr NK Arora, Chairperson of the Covid working group, National Technical Advisory Group on Immunisation (NTAGI) said.
Sep 01, 2022, 07:59 AM IST
SII working to develop COVID-19 booster shot more effective against Omicron: Adar Poonawalla
SII Chief Executive Officer Adar Poonawalla said COVID vaccines for children aged above 3 years will be launched in the next 6 months.
Dec 15, 2021, 06:51 AM IST
Seized COVID vaccine vials not Covishield, Serum Institute tells Kolkata Police
Serum Institute has communicated to Kolkata Police that the seized vials with labels of Covishield vaccine in the fake vaccine case in Kolkata was not Covishield vaccine. For further examination, Kolkata Police has sent those vials to Drug Controller for chemical examination.
Jul 29, 2021, 19:34 PM IST
COVID-19 vaccination for 18-44 age group halted in these states, know the reasons behind the decision
Due to the acute shortage of COVID-19 vaccines in the country, many states have temporarily suspended the vaccination drive for the people in the age group of 18 to 44 and have directed the available stock of doses for the above-45 age group.
May 13, 2021, 07:46 AM IST
Serum Institute clarifies COVID-19 vaccine pricing, 'initial rates low due to advance funding'
Serum Institute of India (SII), which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of Rs 600 per dose and at Rs 400 for state governments and any new contract by the central government. This compared to Rs 150 per dose it charges the central government for the existing supplies.
Apr 24, 2021, 16:52 PM IST
COVID-19: Serum Institute fixes the price of Covishield
The Serum Institute has fixed the price of the Covishield vaccine. For government hospitals, the cost of Covishield will be Rs 400, while the vaccine will be given to private hospitals for Rs 600.
Apr 21, 2021, 14:00 PM IST
CM Uddhav Thackeray will visit Pune today to take stock of the situation of Serum Institute
A massive fire broke out at the new plant of Pune's Serum Institute of India, due to which 5 people are reported dead. All the deceased are said to be working as laborers in the under-construction building. However, this has not affected the production of vaccines. Maharashtra CM, Uddhav Thackeray will visit Pune today to take stock of the situation. PM Modi also expressed grief over this matter.
Jan 22, 2021, 10:36 AM IST
Serum Institute fire: Know what caused the massive blaze that killed 5 people
Maharashtra Health Minister Rajesh Tope said that the initial fire was caused by some ongoing welding work at the site. The fire broke out at about 2:45 pm at an under-construction building where vaccine production was supposed to start after a month. The fire broke out at 4th and 5th floor of the SEZ3 building. BCG vaccine laboratory was there at 3rd floor of the same building but that is unaffected.
Jan 22, 2021, 07:41 AM IST
Dead bodies found on 6th floor of Serum Institute of India, 5 died
A fire broke out in a building at the Serum Institute of India (SII) in Manjari area of Pune. 5 employees lost their lives in this fire. Ten fire engines reached the spot and tried to extinguish the flames.
Jan 21, 2021, 19:16 PM IST
Pune: fire in new building of Serum Institute, the reason is not clear yet
A plant at the Serum Institute of India (SII) in Manjari area of Pune has caught fire. Ten fire engines have reached the spot and efforts are being made to extinguish the flames.
Jan 21, 2021, 17:30 PM IST
Breaking News : Fire broke out at Serum Institute of India in Pune
A massive fire broke out at Serum Institute of India in Pune
Jan 21, 2021, 15:42 PM IST
Covishield vaccine priced at Rs 210 per vial, government order for vaccines
The price of the vaccine has been fixed by the Covishield vaccine manufacturer Pune's Serum Institute at Rs 210 per vial, at which price the manufacturer will make the vaccine available to the govt. After which the government has also given orders for the vaccine.
Jan 12, 2021, 08:22 AM IST
Meet Natasha Poonawalla, the wife of India's vaccine man Adar Poonawalla, in pics
Take a look at some of photos of SII director and philanthropist Natasha Poonawalla, the wife of vaccine man Adar Poonawalla.
Jan 04, 2021, 12:50 PM IST
Know the answer to every question on vaccination in India
In this video, know the answer to every question on vaccination in India.
Jan 04, 2021, 10:26 AM IST
DCGI: Covaxin Vaccine and Covishield Vaccine are both 110% safe
The Serum Institute of India’s Covishield is likely to be vaccinated first in India. Meanwhile, Bharat Biotech’s Covaxin would be used as an option.
Jan 04, 2021, 09:18 AM IST
India: Covishield vaccine to be vaccinated first, Covaxin will remain as an option
The Serum Institute of India’s Covishield is likely to be vaccinated first in India. Meanwhile, Bharat Biotech’s Covaxin would be used as an option.
Jan 04, 2021, 08:24 AM IST
India's COVID vaccine: Amit Shah, JP Nadda, Mayawati, Randeep Singh Surjewala hail scientists, frontline workers for service
Several ministers and political leaders on Sunday (January 3) welcomed India's decision to give emergency use authorisation to Oxford COVID-19 vaccine Covishield and Covaxin of Bharat Biotech for restricted emergency use in the country.
Jan 03, 2021, 14:56 PM IST
